Dyadic International Inc (DYAI)
1.65
-0.01
(-0.60%)
USD |
NASDAQ |
May 17, 16:00
1.66
+0.01
(+0.61%)
After-Hours: 20:00
Dyadic International Enterprise Value: 42.03M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 42.03M |
| May 16, 2024 | 42.32M |
| May 15, 2024 | 39.69M |
| May 14, 2024 | 37.35M |
| May 13, 2024 | 38.52M |
| May 10, 2024 | 36.18M |
| May 09, 2024 | 37.31M |
| May 08, 2024 | 35.60M |
| May 07, 2024 | 35.01M |
| May 06, 2024 | 36.48M |
| May 03, 2024 | 35.60M |
| May 02, 2024 | 37.64M |
| May 01, 2024 | 36.77M |
| April 30, 2024 | 35.60M |
| April 29, 2024 | 34.43M |
| April 26, 2024 | 37.35M |
| April 25, 2024 | 37.35M |
| April 24, 2024 | 37.64M |
| April 23, 2024 | 37.35M |
| April 22, 2024 | 38.52M |
| April 19, 2024 | 40.28M |
| April 18, 2024 | 40.28M |
| April 17, 2024 | 42.91M |
| April 16, 2024 | 46.33M |
| April 15, 2024 | 42.53M |
| Date | Value |
|---|---|
| April 12, 2024 | 45.16M |
| April 11, 2024 | 47.35M |
| April 10, 2024 | 46.62M |
| April 09, 2024 | 49.54M |
| April 08, 2024 | 48.37M |
| April 05, 2024 | 46.62M |
| April 04, 2024 | 48.08M |
| April 03, 2024 | 46.33M |
| April 02, 2024 | 44.87M |
| April 01, 2024 | 42.53M |
| March 31, 2024 | 42.53M |
| March 28, 2024 | 41.12M |
| March 27, 2024 | 39.96M |
| March 26, 2024 | 38.26M |
| March 25, 2024 | 39.99M |
| March 22, 2024 | 38.83M |
| March 21, 2024 | 39.70M |
| March 20, 2024 | 40.85M |
| March 19, 2024 | 38.55M |
| March 18, 2024 | 38.26M |
| March 15, 2024 | 35.95M |
| March 14, 2024 | 36.53M |
| March 13, 2024 | 38.83M |
| March 12, 2024 | 35.38M |
| March 11, 2024 | 34.80M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
19.50M
Minimum
Dec 13 2022
250.55M
Maximum
Jun 22 2020
88.79M
Average
79.57M
Median
Enterprise Value Benchmarks
| AIM ImmunoTech Inc | 7.729M |
| Perspective Therapeutics Inc | 817.27M |
| Protalix BioTherapeutics Inc | 55.51M |
| Electromed Inc | 130.07M |
| Armata Pharmaceuticals Inc | 187.82M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.010M |
| Revenue (Quarterly) | 0.3346M |
| Total Expenses (Quarterly) | 2.455M |
| EPS Diluted (Quarterly) | -0.07 |
| Gross Profit Margin (Quarterly) | 56.98% |
| Profit Margin (Quarterly) | -600.6% |
| Earnings Yield | -16.97% |
| Normalized Earnings Yield | -19.17 |